close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

LLY

936.53

+0.86%↑

JNJ

186.34

-0.01%↓

UNH

321.47

-2%↓

NVS

126.4

+0.75%↑

ABT

124.91

+0.22%↑

Strona główna・Stock List・Nektar Therapeutics
Search

Nektar Therapeutics

Closed

54.68 1.13

Buy

Price update 6 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

53.95

Max

57.28

Key metrics

By Trading Economics

Income

9.3M

-42M

Sales

715K

11M

EPS

-2.78

Profit margin

-372.197

Employees

61

EBITDA

4.7M

-36M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+72.98% upside

Market Stats

By TradingEconomics

Market Cap

736M

1.1B

Previous open

53.55

Previous close

54.68

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

6 lis 2025, 23:38 UTC

Earnings

OCBC Posts Steady Third-Quarter Net Profit, Drop in Net Interest Income

DJ

Read

6 lis 2025, 23:00 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts -- Update

DJ

Read

6 lis 2025, 22:19 UTC

Earnings
Major Market Movers

Block Shares Slide After 3Q Results Miss Estimates

DJ

Read

6 lis 2025, 21:53 UTC

Earnings

Macquarie's First-Half Profit Grows 2.7%, Missing Forecasts

DJ

Read

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Sales $476M >WPM

DJ

Read

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q Adj EPS 61.8c >WPM

DJ

Read

6 lis 2025, 23:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

6 lis 2025, 23:45 UTC

Market Talk

Nikkei May Fall After U.S. Tech Stocks Drop

DJ

Read

6 lis 2025, 23:45 UTC

Earnings

Wheaton Precious Metals 3Q EPS 80.7c >WPM

DJ

Read

6 lis 2025, 23:38 UTC

Market Talk

Gold Edges Higher Amid Worrisome Signs for U.S. Economy -- Market Talk

DJ

Read

6 lis 2025, 23:15 UTC

Earnings

Kakao 3Q Net Profit Beat FactSet-Compiled Consensus

DJ

Read

6 lis 2025, 23:14 UTC

Earnings

Kakao 3Q Net KRW192.86B Vs. Net KRW78.51B >035720.SE

DJ

Read

6 lis 2025, 23:14 UTC

Earnings

Kakao 3Q Oper Pft KRW208.05B Vs. Pft KRW130.53B >035720.SE

DJ

Read

6 lis 2025, 23:13 UTC

Earnings

Kakao 3Q Rev KRW2.087T Vs. KRW1.921T >035720.SE

DJ

Read

6 lis 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Total Income S$3.80B Vs. S$3.80B >O39.SG

DJ

Read

6 lis 2025, 23:08 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Noninterest Income S$1.57B Vs. S$1.37B >O39.SG

DJ

Read

6 lis 2025, 23:07 UTC

Earnings

Oversea-Chinese Banking Corp. 3Q Net S$1.98B Vs. Net S$1.97B >O39.SG

DJ

Read

6 lis 2025, 23:07 UTC

Earnings

Suzano 3Q Rev BRL12.2B >SUZ

DJ

Read

6 lis 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Pay Waterton Gold $670M Up Front

DJ

Read

6 lis 2025, 22:47 UTC

Acquisitions, Mergers, Takeovers

Wheaton Precious Metals to Buy Gold Stream on Spring Valley Project Located in Nevada >WPM

DJ

Read

6 lis 2025, 22:45 UTC

Acquisitions, Mergers, Takeovers

Union Pacific and Norfolk Southern Provide Supplemental Disclosures to Joint Proxy Statement About Merger

DJ

Read

6 lis 2025, 22:25 UTC

Acquisitions, Mergers, Takeovers

At Bank of America's Investor Day, M&A Hints, Would-Be CEOs, and AI Pitches -- Barrons.com

DJ

Read

6 lis 2025, 22:13 UTC

Earnings

Fairfax Financial 3Q Rev $8.27B >FFH.T

DJ

Read

6 lis 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Sales $632.2M >CENX

DJ

Read

6 lis 2025, 22:02 UTC

Earnings

Century Aluminum 3Q Adj EPS 56c >CENX

DJ

Read

6 lis 2025, 21:53 UTC

Earnings

DraftKings Stock Sinks on Disappointing Results -- Barrons.com

DJ

Read

6 lis 2025, 21:52 UTC

Acquisitions, Mergers, Takeovers

Universal Display: Portfolio Includes More Than 300 Issued and Pending Patents Worldwide, Covering More Than 110 Unique Patent Families >OLED

DJ

Read

6 lis 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Universal Display Corp to Acquire Emissive OLED Patent Assets From Merck KGaA, Darmstadt, Germany

DJ

Read

6 lis 2025, 21:50 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

6 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

72.98% upside

12 Months Forecast

Average 93.86 USD  72.98%

High 120 USD

Low 30 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

6

Buy

1

Hold

1

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Short Term

Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

Bearish Evidence

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

936.53

↑ +0.86%

JNJ

Johnson and Johnson

186.34

↓-0.01%

UNH

UnitedHealth Group Inc

321.47

↓-2%

NVS

Novartis AG

126.4

↑ +0.75%

ABT

Abbott Laboratories

124.91

↑ +0.22%
help-icon Live chat